Tech Company Inital Public Offerings
Shattuck Labs IPO
Operating out of Durham, Shattuck Labs is now a public company.
Transaction Overview
Company Name
Announced On
10/8/2020
Transaction Type
IPO
Amount
$202,300,000
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows:to advance SL-172154 through the completion of our ongoing and planned Phase 1 clinical trials and to commence a Phase 2 clinical program;to advance SL-279252 through the completion of our ongoing Phase 1 clinical trial; andto develop and advance additional product candidates derived from our platforms through IND-enabling studies and to commence Phase 1 clinical trials.the remainder of the net proceeds for working capital and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
21 Parmer Way 200
Durham, NC 27709
USA
Durham, NC 27709
USA
Phone
Website
Email Address
Overview
Shattuck (Nasdaq: STTK) is developing a breakthrough platform for immunotherapy, which harnesses the human immune system to improve outcomes for patients battling cancer and inflammatory disease. Shattuck's proprietary technology represents the next evolutionary step in cancer therapy by endowing one molecule with multiple, synergistic functions.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 10/8/2020: Shogun venture capital transaction
Next: 10/8/2020: Redaptive venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs